文献速递妇产影像技术与安全US

妊娠期高血压疾病的血流动力学指导治疗:系统综述与荟萃分析

Hemodynamics-guided treatment of hypertensive disorders of pregnancy: systematic review and meta-analysis.
PubMed 文献 · Ultrasound Obstet Gynecol · 2026-06-11

本系统综述与荟萃分析纳入6项比较血流动力学指导降压与标准血压阈值管理在妊娠期高血压疾病女性中的研究。血流动力学指导治疗可降低子痫前期/子痫、重度高血压、胎儿生长受限及早产的发生风险。总体证据质量按GRADE评估为低至极低。

要点

  • 血流动力学指导降压或可降低子痫前期/子痫及胎儿生长受限风险。
  • 相关证据质量低至极低,结论应被视为产生假设而非确立推荐。
  • 临床应用需注意所纳入研究以非随机设计为主,存在残余混杂。

核心结论

  • 血流动力学指导的抗高血压管理与标准血压阈值管理相比,或可降低多种母胎不良结局的风险。
  • 由于非随机研究占多数且证据质量低至极低,该关联需经充分把握度的随机对照试验确认。

研究设计与样本

  • 系统综述与荟萃分析,纳入比较血流动力学指导管理与标准降压管理的随机及非随机对照研究。
  • 检索PubMed/MEDLINE与Cochrane Library自建库至2025年6月15日,共纳入6项研究。
  • 包括1项随机对照试验、4项非随机对照研究及1项多中心前瞻性队列研究。
  • 干预组纳入418–614例患者,对照组纳入617–731例患者,具体样本量因结局而异。
  • 采用ROBINS-I、修订版Cochrane偏倚风险工具及Newcastle-Ottawa量表评估偏倚风险,并以GRADE评估证据质量。

诊断标准与关键数值

  • 血流动力学指导治疗与子痫前期/子痫风险降低53%相关(OR,0.47;95% CI,0.33–0.65;I²=0%)。
  • 血流动力学指导治疗与重度高血压风险降低61%相关(OR,0.39;95% CI,0.18–0.88;I²=31%)。
  • 血流动力学指导治疗与胎儿生长受限风险降低46%相关(OR,0.54;95% CI,0.38–0.76;I²=0%)。
  • 血流动力学指导治疗与早产风险降低60%相关(OR,0.40;95% CI,0.16–0.99;I²=80%)。
  • 复合不良结局的OR为0.27(95% CI,0.21–0.36;I²=0%),总体GRADE证据质量为低至极低。

临床应用与阅片要点

  • 血流动力学指标可能有助于识别需要强化降压管理的妊娠期高血压疾病患者,但尚不宜直接取代血压阈值标准。
  • 报告相关超声血流动力学参数时需注明测量设备、方案与参考范围,因纳入研究间存在测量异质性。
  • 解读相关文献时需警惕非随机设计带来的残余混杂,不宜直接推定因果关系。

局限性

  • 纳入研究以非随机设计为主,存在残余混杂风险。
  • 各项研究间血流动力学测量存在异质性。
  • 总体GRADE证据质量为低至极低,结论强度有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To determine whether antihypertensive therapy guided by maternal hemodynamic assessment improves maternal and perinatal outcomes in women with hypertensive disorders of pregnancy (HDP) compared with standard care based on blood-pressure thresholds.

METHODS: This was a systematic review and meta-analysis of randomized and non-randomized comparative studies comparing hemodynamics-guided management vs standard antihypertensive care in women with HDP. PubMed/MEDLINE and The Cochrane Library were searched from inception until 15 June 2025 for eligible studies. Outcome data were extracted for pre-eclampsia/eclampsia, HELLP syndrome, severe hypertension, fetal growth restriction, placental abruption, preterm birth and perinatal death. The composite adverse outcome included all abovementioned outcomes. The risk of bias was assessed using the Risk Of Bias In Non-Randomized Studies of Interventions tool, the revised Cochrane Risk-of-Bias tool and the Newcastle-Ottawa scale. Certainty of evidence was assessed using Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology. Odds ratios (OR) were pooled using random-effects models, with heterogeneity quantified by I2. Leave-one-out analyses were performed to investigate sensitivity to outliers.

RESULTS: The literature search retrieved six studies, including one randomized controlled trial, four non-randomized comparative studies and one multicenter prospective cohort study. Depending on the outcome analyzed, 418-614 patients were included in the intervention group and 617-731 patients in the control group. Compared with standard care, hemodynamics-guided therapy reduced the odds of pre-eclampsia/eclampsia by 53% (OR, 0.47 (95% CI, 0.33-0.65); I2 = 0%), severe hypertension by 61% (OR, 0.39 (95% CI, 0.18-0.88); I2 = 31%), fetal growth restriction by 46% (OR, 0.54 (95% CI, 0.38-0.76); I2 = 0%) and preterm birth by 60% (OR, 0.40 (95% CI, 0.16-0.99); I2 = 80%). The OR for the composite adverse outcome was 0.27 (95% CI, 0.21-0.36) (I2 = 0%). The overall certainty of evidence according to the GRADE framework was low to very low.

CONCLUSIONS: Hemodynamics-guided antihypertensive management of women with HDP was associated with reductions in several adverse maternal and perinatal outcomes compared with standard care. Given the predominance of non-randomized study designs, measurement heterogeneity and risk of residual confounding, these associations should be interpreted as hypothesis-generating and require confirmation in adequately powered randomized controlled trials. © 2026 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Novelli, Vasapollo, Attini, et al. Hemodynamics-guided treatment of hypertensive disorders of pregnancy: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2026. PMID: 42277996. doi:10.1002/uog.70250

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。